Product Information
GLYXAMBI 25 MG-5 MG TABLET is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $11.1987 per EA under NDC 00597016490. Its NADAC has been published 592 times since Apr 22, 2015.
FDA first approved this application on Jan 30, 2015.
Strength
25; 5 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597016490
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EMPAGLIFLOZIN; LINAGLIPTINApproval Type
New Drug (NDA)
FDA Application
NDA206073FDA Approved
1/30/2015
On Market Since
1/30/2015
Pharmacological Classes
Price Statistics
The NADAC for GLYXAMBI 25 MG-5 MG TABLET has been published 592 times since Apr 22, 2015, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1987 per EA |
|---|---|
| All-time high | $20.1302 (May 14, 2025) |
| All-time low | $11.1925 (Jan 7, 2026) |
| 52-week high | $20.1282 |
| 52-week low | $11.1925 |
| Median price | $17.2893 |
| Average price | $17.3597 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 592 |
| Tracking since | Apr 22, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYXAMBI 25 MG-5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYXAMBI 25 MG-5 MG TABLET, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $11.1987 per EA (NDC 00597016490), effective Aug 19, 2026.
How has the price of GLYXAMBI 25 MG-5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYXAMBI 25 MG-5 MG TABLET has declined 23.4%. It has been tracked across 592 weekly CMS publications since Apr 22, 2015.
What are the highest and lowest recorded NADAC prices for GLYXAMBI 25 MG-5 MG TABLET?
Since Apr 22, 2015, the NADAC for GLYXAMBI 25 MG-5 MG TABLET has ranged from a low of $11.1925 (Jan 7, 2026) to a high of $20.1302 (May 14, 2025), with a median of $17.2893 per EA.
Are there cheaper alternatives to GLYXAMBI 25 MG-5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GLYXAMBI 25 MG-5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GLYXAMBI 25 MG-5 MG TABLET?
GLYXAMBI 25 MG-5 MG TABLET (NDC 00597016490) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.